Adaptive Biotechnologies Corp

Biotechnology company · Seattle, Washington, United States · Nasdaq: ADPT

Adaptive Biotechnologies Corp is a biotechnology company headquartered in Seattle, Washington, United States. Its earliest recorded incorporation is in 2009. Its shares trade on Nasdaq under the ticker ADPT. The US FDA lists 2 medical device sites registered to the company, with devices in pathology. It has received 7 US government small-business research awards (SBIR/STTR) from health agencies, $4.5 million in total, most recently in 2017. It has reported private securities offerings to the US SEC, most recently $195 million sold in a notice filed in 2015.

Profile compiled from public records. Is this your company? Request a correction or update

Adaptive Biotechnologies at a glance

Typebiotechnology company
HeadquartersSeattle, Washington, United States
Earliest incorporation on record2009
Stock listingNasdaq: ADPT
SEC industryBiological Products, (No Diagnostic Substances)
FDA-registered sites2
SEC CIK1478320

What does Adaptive Biotechnologies do?

Medical specialties of its FDA-listed devices

Pathology

Device types listed with the FDA

Dna-based test for minimal residual disease for hematologic malignancies

US government research funding

7 SBIR/STTR small-business research awards from US health agencies, $4.5 million in total (2010 to 2017). NIH funding came from the National Heart, Lung, and Blood Institute.

Private fundraising reported to the SEC

6 Form D notices; the most recent reported $195.1 million sold (2015).

Where is Adaptive Biotechnologies located?

Headquarters: Seattle, Washington, United States

  • Bothell, WashingtonAdaptive Biotechnologies · FDA device site
  • Seattle, WashingtonAdaptive Biotechnologies · FDA device site

Frequently asked questions about Adaptive Biotechnologies

Where is Adaptive Biotechnologies headquartered?

Adaptive Biotechnologies Corp is headquartered in Seattle, Washington, United States.

What does Adaptive Biotechnologies do?

Adaptive Biotechnologies Corp is a biotechnology company. Its FDA-listed medical devices fall under pathology. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is Adaptive Biotechnologies a public company?

Yes. Adaptive Biotechnologies Corp trades on Nasdaq under the ticker ADPT.

When was Adaptive Biotechnologies founded?

The earliest incorporation on record for Adaptive Biotechnologies Corp is in 2009, according to public company registers.

How many FDA-registered sites does Adaptive Biotechnologies have?

The US FDA lists 2 registered sites for Adaptive Biotechnologies Corp.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes